(Untitled)

Welcome to my Drug Sciences Hub

I help make sure medicines are safe for the people who rely on them, combining more than ten years of hospital and community pharmacy with research into drug-induced immune responses.

Trusted by

I can describe Elena as a friendly kind, trustworthy, relaxed, and mature person who treats people with respect and kindness.

Katerina Oliphant, Pharmacist

As a pharmacist she knows to treat all patients with empathy, making complete and complex pharmaceutical

Dr. Elena Gheorghiu, Senior Pharmacist

Mrs. Pintea showed a high level of knowledge in the pharmaceutical domain, with developed interpersonal skills with regards to her colleagues and took part in team activities revealing her team spirit.

Coinac Tatiana, Director Farmacia “Receta Farm” SRL

Latest

Oct 14
From the pharmacy counter to Swissmedic

From the pharmacy counter to Swissmedic: how a suspected ADR gets reported

Pharmacovigilance does not start in a safety database. It starts when a patient says, "Since I started these tablets, something isn't right." What happens next determines whether that observation becomes useful safety data or is lost.
4 min read
Oct 12
Two ICH guidelines shape how drug developers assess effects on the immune system before human use: ICH S8 for immunotoxicity of pharmaceuticals, and ICH S6(R1) for biotechnology-derived produ

ICH S8 and S6 in plain language: immunotoxicity for small molecules vs biologics

Two ICH guidelines shape how drug developers assess effects on the immune system before human use: ICH S8 for immunotoxicity of pharmaceuticals, and ICH S6(R1) for biotechnology-derived products. They answer the same broad question, but in different ways.
3 min read
Oct 12
Cytokine release

Cytokine release and first-in-human trials: the lessons of TGN1412

In March 2006, six healthy volunteers in London received a new monoclonal antibody called TGN1412. Within hours, all six developed a severe cytokine storm and needed intensive care (Suntharalingam et al., 2006). All survived, but the trial changed how the industry and regulators approach first-in-hu
4 min read
Oct 12
When the immune system is the adverse event

When the immune system is the adverse event: what macrophage research teaches drug safety

My master's thesis at the University of Basel focused on one of those cells: the macrophage. In this article I explain why macrophages matter for drug safety and what laboratory work on them teaches about recognising immune-mediated harm.
4 min read